Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease

Kazuki Fukuchi, Kazuo Hashikawa, Yujiro Seike, Hiroshi Moriwaki, Naohiko Oku, Mariko Ishida, Masahiro Fujita, Toshiisa Uehara, Hirotaka Tanabe, Hideo Kusuoka, Tsunehiko Nishimura

Research output: Contribution to journalArticle

Abstract

This study was designed to elucidate a central type of benzodiazepine (Bz) receptor distribution in patients with Alzheimer's disease using SPECT with [123I]iornazenil (IMZ). Methods: Eight patients with probable Alzheimer's disease were studied. Benzodiazepine receptor imaging was performed 15 min (early) and 180 min (delayed) after intravenous administration of 167 MBq IMZ, sequentially, using hexamethylpropylene amine oxime (HMPAO) SPECT to evaluate regional cerebral perfusion. Results: Early IMZ-SPECT depicted areas of reduced uptake in sites of decreased cerebral blood flow (CBF), but each area of decreased uptake was extended wider than the area of hypoperfusion. Delayed IMZ-SPECT images demonstrated a similar pattern of decreased area of CBF; the affected region in Bz receptor bindings, however, was clearer and broader compared with that in either HMPAO-SPECT or early IMZ-SPECT. In comparison with the uptakes for the normal cerebral hemisphere (ratio to the contralateral cerebellum) in patients with unilateral cerebral infarction as a control group (n = 4), the patients with Alzheimer's disease showed distinctive bilateral frontal or parietal defects (p <0.05). Conclusion: Brain SPECT using IMZ may be more sensitive than CBF images in patients with Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)467-470
Number of pages4
JournalJournal of Nuclear Medicine
Volume38
Issue number3
StatePublished - Mar 1997
Externally publishedYes

Fingerprint

Oximes
Technetium
Single-Photon Emission-Computed Tomography
Iodine
Amines
Alzheimer Disease
Cerebrovascular Circulation
GABA-A Receptors
Cerebral Infarction
Cerebrum
iomazenil
Intravenous Administration
Cerebellum
Perfusion
Control Groups
Brain

Keywords

  • Alzheimer's disease
  • Benzodiazepine receptor
  • Iodine-123- iomazenil
  • Technetium-99m-HMPAO

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Fukuchi, K., Hashikawa, K., Seike, Y., Moriwaki, H., Oku, N., Ishida, M., ... Nishimura, T. (1997). Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease. Journal of Nuclear Medicine, 38(3), 467-470.

Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease. / Fukuchi, Kazuki; Hashikawa, Kazuo; Seike, Yujiro; Moriwaki, Hiroshi; Oku, Naohiko; Ishida, Mariko; Fujita, Masahiro; Uehara, Toshiisa; Tanabe, Hirotaka; Kusuoka, Hideo; Nishimura, Tsunehiko.

In: Journal of Nuclear Medicine, Vol. 38, No. 3, 03.1997, p. 467-470.

Research output: Contribution to journalArticle

Fukuchi, K, Hashikawa, K, Seike, Y, Moriwaki, H, Oku, N, Ishida, M, Fujita, M, Uehara, T, Tanabe, H, Kusuoka, H & Nishimura, T 1997, 'Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease', Journal of Nuclear Medicine, vol. 38, no. 3, pp. 467-470.
Fukuchi K, Hashikawa K, Seike Y, Moriwaki H, Oku N, Ishida M et al. Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease. Journal of Nuclear Medicine. 1997 Mar;38(3):467-470.
Fukuchi, Kazuki ; Hashikawa, Kazuo ; Seike, Yujiro ; Moriwaki, Hiroshi ; Oku, Naohiko ; Ishida, Mariko ; Fujita, Masahiro ; Uehara, Toshiisa ; Tanabe, Hirotaka ; Kusuoka, Hideo ; Nishimura, Tsunehiko. / Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease. In: Journal of Nuclear Medicine. 1997 ; Vol. 38, No. 3. pp. 467-470.
@article{cbe427e60c88428a8d8fe012afdb60af,
title = "Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease",
abstract = "This study was designed to elucidate a central type of benzodiazepine (Bz) receptor distribution in patients with Alzheimer's disease using SPECT with [123I]iornazenil (IMZ). Methods: Eight patients with probable Alzheimer's disease were studied. Benzodiazepine receptor imaging was performed 15 min (early) and 180 min (delayed) after intravenous administration of 167 MBq IMZ, sequentially, using hexamethylpropylene amine oxime (HMPAO) SPECT to evaluate regional cerebral perfusion. Results: Early IMZ-SPECT depicted areas of reduced uptake in sites of decreased cerebral blood flow (CBF), but each area of decreased uptake was extended wider than the area of hypoperfusion. Delayed IMZ-SPECT images demonstrated a similar pattern of decreased area of CBF; the affected region in Bz receptor bindings, however, was clearer and broader compared with that in either HMPAO-SPECT or early IMZ-SPECT. In comparison with the uptakes for the normal cerebral hemisphere (ratio to the contralateral cerebellum) in patients with unilateral cerebral infarction as a control group (n = 4), the patients with Alzheimer's disease showed distinctive bilateral frontal or parietal defects (p <0.05). Conclusion: Brain SPECT using IMZ may be more sensitive than CBF images in patients with Alzheimer's disease.",
keywords = "Alzheimer's disease, Benzodiazepine receptor, Iodine-123- iomazenil, Technetium-99m-HMPAO",
author = "Kazuki Fukuchi and Kazuo Hashikawa and Yujiro Seike and Hiroshi Moriwaki and Naohiko Oku and Mariko Ishida and Masahiro Fujita and Toshiisa Uehara and Hirotaka Tanabe and Hideo Kusuoka and Tsunehiko Nishimura",
year = "1997",
month = "3",
language = "English (US)",
volume = "38",
pages = "467--470",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of iodine-123-iomazenil spect and technetium-99m-HMPAO-SPECT in Alzheimer's disease

AU - Fukuchi, Kazuki

AU - Hashikawa, Kazuo

AU - Seike, Yujiro

AU - Moriwaki, Hiroshi

AU - Oku, Naohiko

AU - Ishida, Mariko

AU - Fujita, Masahiro

AU - Uehara, Toshiisa

AU - Tanabe, Hirotaka

AU - Kusuoka, Hideo

AU - Nishimura, Tsunehiko

PY - 1997/3

Y1 - 1997/3

N2 - This study was designed to elucidate a central type of benzodiazepine (Bz) receptor distribution in patients with Alzheimer's disease using SPECT with [123I]iornazenil (IMZ). Methods: Eight patients with probable Alzheimer's disease were studied. Benzodiazepine receptor imaging was performed 15 min (early) and 180 min (delayed) after intravenous administration of 167 MBq IMZ, sequentially, using hexamethylpropylene amine oxime (HMPAO) SPECT to evaluate regional cerebral perfusion. Results: Early IMZ-SPECT depicted areas of reduced uptake in sites of decreased cerebral blood flow (CBF), but each area of decreased uptake was extended wider than the area of hypoperfusion. Delayed IMZ-SPECT images demonstrated a similar pattern of decreased area of CBF; the affected region in Bz receptor bindings, however, was clearer and broader compared with that in either HMPAO-SPECT or early IMZ-SPECT. In comparison with the uptakes for the normal cerebral hemisphere (ratio to the contralateral cerebellum) in patients with unilateral cerebral infarction as a control group (n = 4), the patients with Alzheimer's disease showed distinctive bilateral frontal or parietal defects (p <0.05). Conclusion: Brain SPECT using IMZ may be more sensitive than CBF images in patients with Alzheimer's disease.

AB - This study was designed to elucidate a central type of benzodiazepine (Bz) receptor distribution in patients with Alzheimer's disease using SPECT with [123I]iornazenil (IMZ). Methods: Eight patients with probable Alzheimer's disease were studied. Benzodiazepine receptor imaging was performed 15 min (early) and 180 min (delayed) after intravenous administration of 167 MBq IMZ, sequentially, using hexamethylpropylene amine oxime (HMPAO) SPECT to evaluate regional cerebral perfusion. Results: Early IMZ-SPECT depicted areas of reduced uptake in sites of decreased cerebral blood flow (CBF), but each area of decreased uptake was extended wider than the area of hypoperfusion. Delayed IMZ-SPECT images demonstrated a similar pattern of decreased area of CBF; the affected region in Bz receptor bindings, however, was clearer and broader compared with that in either HMPAO-SPECT or early IMZ-SPECT. In comparison with the uptakes for the normal cerebral hemisphere (ratio to the contralateral cerebellum) in patients with unilateral cerebral infarction as a control group (n = 4), the patients with Alzheimer's disease showed distinctive bilateral frontal or parietal defects (p <0.05). Conclusion: Brain SPECT using IMZ may be more sensitive than CBF images in patients with Alzheimer's disease.

KW - Alzheimer's disease

KW - Benzodiazepine receptor

KW - Iodine-123- iomazenil

KW - Technetium-99m-HMPAO

UR - http://www.scopus.com/inward/record.url?scp=0030967717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030967717&partnerID=8YFLogxK

M3 - Article

C2 - 9074540

AN - SCOPUS:0030967717

VL - 38

SP - 467

EP - 470

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 3

ER -